GO:0008251 tRNA-specific adenosine deaminase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008251 describes the molecular function of catalyzing adenosine to inosine conversion specifically within tRNA molecules.
• This activity is essential for wobble position modification, enabling efficient and accurate translation of genetic code.
• The enzyme is conserved from bacteria to humans, with homologs such as Tad1p in yeast and ADAT1/ADAT2 in mammals.
• Dysregulation of tRNA-specific adenosine deaminase activity is linked to colorectal cancer progression and chemoresistance.
• Mutations in the related ADAR gene cause dyschromatosis symmetrica hereditaria, highlighting the importance of adenosine deaminases in human disease.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) are powerful tools to dissect the function of this activity in health and disease.
Description
tRNA-specific adenosine deaminase activity (GO:0008251) is a molecular function that converts adenosine to inosine within tRNA molecules. This modification, particularly at the wobble position of the anticodon, is critical for decoding flexibility and translational fidelity. The enzyme responsible belongs to the ADAT family, which shares evolutionary ties with pre-mRNA editing enzymes ADAR1 and ADAR2. Understanding this activity is vital because it impacts protein synthesis, cellular stress responses, and has been implicated in cancer and other diseases. Researchers study it using biochemical assays, structural biology, and CRISPR-based genetic models.
tRNA-specific adenosine deaminase activity At A Glance
| GO ID | GO:0008251 |
|---|---|
| GO term | tRNA-specific adenosine deaminase activity |
| Ontology | molecular_function |
| Synonym | tRNA-adenosine deaminase activity |
| Major function | Catalyzes adenosine to inosine conversion in tRNA |
| Reaction | adenosine + H2O = inosine + NH4+ |
| Substrate | tRNA adenosine |
| Product | tRNA inosine |
What Is GO:0008251?
tRNA-specific adenosine deaminase activity is defined as the catalysis of the reaction adenosine + H2O = inosine + NH4+ within a tRNA molecule. This hydrolytic deamination specifically targets adenosine in tRNA, distinguishing it from similar activities on other RNA substrates.
Why Is tRNA-specific adenosine deaminase activity Important in Cell Biology?
This activity is crucial for translational efficiency and accuracy, as inosine at the wobble position expands codon recognition. It is conserved across species and defects are linked to human diseases, including cancer and pigmentation disorders. Studying it provides insights into RNA modification biology and potential therapeutic targets.
• Enables wobble base pairing and decoding of multiple codons.
• Essential for efficient protein synthesis under normal and stress conditions.
• Conserved from bacteria to humans, with homologs in yeast and Drosophila.
• Implicated in colorectal cancer progression and chemoresistance.
• Mutations in related ADAR gene cause dyschromatosis symmetrica hereditaria.
• Potential target for antiviral and anticancer therapies.
• Required for proper tRNA maturation and stability.
• Influences cellular response to stress and immune signaling.
What Happens During tRNA-specific adenosine deaminase activity?
Substrate Recognition and Binding
In simple terms: The enzyme finds and grabs the tRNA molecule.
The enzyme specifically recognizes tRNA substrates through structural elements, including the anticodon loop. It binds adenosine within the tRNA and positions it for catalysis.
Catalytic Deamination
In simple terms: The enzyme chemically changes adenosine into inosine.
A water molecule attacks the adenosine, leading to hydrolytic deamination that converts adenosine to inosine and releases ammonium. This reaction is dependent on the enzyme's active site residues.
Product Release and tRNA Maturation
In simple terms: The modified tRNA is released and ready to function.
After deamination, the inosine-containing tRNA is released and participates in translation, where inosine can pair with multiple bases. This modification enhances decoding capacity.
Regulation and Quality Control
In simple terms: The cell controls how much of this modification happens.
The activity can be regulated at expression levels and through interacting proteins, ensuring proper tRNA modification under varying conditions. Quality control mechanisms may degrade improperly modified tRNAs.
Key Genes Involved in GO:0008251 tRNA-specific adenosine deaminase activity
Key genes encoding tRNA-specific adenosine deaminases and related proteins are listed below.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ADAT1 | tRNA-specific adenosine deaminase in eukaryotes | Catalyzes inosine formation at position 37 in tRNA |
| ADAT2 | Subunit of tRNA adenosine deaminase complex | Forms heterodimer with ADAT3 for wobble inosine |
| ADAT3 | Subunit of tRNA adenosine deaminase complex | Mutations cause intellectual disability |
| TAD1 | Yeast tRNA-specific adenosine deaminase | Model for studying enzyme mechanism |
| yaaJ | Bacterial tRNA adenosine deaminase | Dispensable in Bacillus subtilis |
| ADAR1 | Pre-mRNA editing enzyme, related to ADATs | Evolutionary link and disease relevance |
| ADAR2 | Pre-mRNA editing enzyme, related to ADATs | Evolutionary link and disease relevance |
| DmADAT | Drosophila tRNA adenosine deaminase | Supports evolutionary link |
| ADAT1 (murine) | Murine tRNA adenosine deaminase | Functional expression studies |
| ADAT2 (human) | Human tRNA adenosine deaminase | Cancer progression and chemoresistance |
| ADAT3 (human) | Human tRNA adenosine deaminase | Intellectual disability and cancer |
| Tad1p | Yeast tRNA adenosine deaminase | Related to ADARs |
| ADAT (Drosophila) | Drosophila tRNA adenosine deaminase | Evolutionary link |
| ADAT1 (human) | Human tRNA adenosine deaminase | Detection methods |
| ADAT2/3 complex | Heterodimeric tRNA deaminase | Wobble inosine modification |
| ADAR | RNA editing enzyme | Mutations cause DSH |
| yaaJ (B. subtilis) | Bacterial tRNA deaminase | Dispensable for growth |
| ADAT (murine) | Murine tRNA deaminase | Genomic organization |
How Is tRNA-specific adenosine deaminase activity Regulated?
The activity is regulated at multiple levels, including transcriptional control of ADAT genes and post-translational modifications. In cancer, ADAT2 expression is upregulated to promote oncogenic translation. Additionally, the enzyme's activity may be modulated by cellular stress and metabolic state.
tRNA-specific adenosine deaminase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ADAT2 | Colorectal cancer progression and chemoresistance | Knockout and overexpression in cancer cell lines |
| ADAR | Dyschromatosis symmetrica hereditaria | Point mutation knock-in in mice |
| ADAT3 | Intellectual disability | Knockout in neuronal cells |
| ADAT1 | Not directly linked to disease | Knockout in model organisms |
| yaaJ | Dispensable in B. subtilis | Knockout in Bacillus subtilis |
Colorectal Cancer
ADAT2-mediated tRNA modification promotes oncogenic translation and chemoresistance in colorectal cancer. Targeting this activity may overcome resistance.
Dyschromatosis Symmetrica Hereditaria
Mutations in the related ADAR gene cause this pigmentation disorder, highlighting the importance of adenosine deaminases in human disease.
Neurological Disorders
ADAT3 mutations are associated with intellectual disability, linking tRNA modification to brain development.
From tRNA-specific adenosine deaminase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is the gene essential for viability? | Knockout cell lines |
| Does a specific mutation affect catalytic activity? | Point mutation knock-in |
| How does the enzyme interact with partners? | Tagged knock-in for proteomics |
| What is the effect of overexpression? | Overexpression cell lines |
| Can we rescue a disease phenotype? | Knock-in of wild-type or mutant gene |
| What are the downstream targets? | Knockout followed by Ribo-seq |
How to Study the tRNA-specific adenosine deaminase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| tRNA deaminase activity assay | Enzymatic conversion of adenosine to inosine | Quantify activity in cell lysates |
| X-ray crystallography | Three-dimensional structure | Understand catalytic mechanism |
| Ribo-seq | Translation efficiency and codon usage | Assess impact on protein synthesis |
| RNA-seq | Gene expression changes | Identify downstream pathways |
| CRISPR knockout | Gene function | Determine essentiality |
| Site-directed mutagenesis | Effect of point mutations | Validate catalytic residues |
| Proteomics | Protein interactions | Identify binding partners |
| In vitro deamination assay | Kinetic parameters | Characterize enzyme variants |
Biochemical Assays
Detection of tRNA-specific adenosine deaminase activity in cell lysates using radioactive or fluorescent substrates.
Structural Biology
X-ray crystallography and cryo-EM to determine enzyme structure and catalytic mechanism.
Next-Generation Sequencing
RNA-seq and Ribo-seq to assess changes in tRNA modification and translation efficiency upon perturbation.
CRISPR Screening
Genome-wide knockout screens to identify genes that modulate sensitivity to deaminase inhibition.
How CRISPR Can Be Used to Study GO:0008251 tRNA-specific adenosine deaminase activity
Knockout
CRISPR knockout of ADAT genes can reveal their essentiality and impact on translation and disease phenotypes.
Point Mutation
Introducing specific point mutations in catalytic residues allows precise dissection of enzyme mechanism.
Knock-in
Knock-in of tagged or mutant versions enables tracking and functional studies in endogenous context.
Overexpression
Overexpression of ADAT2/3 can model oncogenic translation and chemoresistance in cancer cells.
How EDITGENE Supports tRNA-specific adenosine deaminase activity Research
Researchers studying tRNA-specific adenosine deaminase activity-related genes often need to determine whether a candidate gene is causally involved in a specific phenotype, such as cancer progression or neurological disorder. EDITGENE provides comprehensive CRISPR services to create precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for tRNA-specific adenosine deaminase activity research.
Frequently Asked Questions About tRNA-specific adenosine deaminase activity
What is tRNA-specific adenosine deaminase activity?
It is the enzymatic conversion of adenosine to inosine within tRNA molecules, crucial for translation.
What genes are involved in tRNA-specific adenosine deaminase activity?
Key genes include ADAT1, ADAT2, ADAT3 in humans, Tad1p in yeast, and yaaJ in bacteria.
How is tRNA-specific adenosine deaminase activity regulated?
It is regulated at transcriptional and post-translational levels, and by cellular stress.
What diseases are associated with tRNA-specific adenosine deaminase activity?
Colorectal cancer, dyschromatosis symmetrica hereditaria, and intellectual disability.
What methods are used to study tRNA-specific adenosine deaminase activity?
Biochemical assays, structural biology, Ribo-seq, and CRISPR screens.
Is tRNA-specific adenosine deaminase activity essential for life?
In some organisms like Bacillus subtilis, the enzyme is dispensable, but in others it is important for fitness.
How does tRNA-specific adenosine deaminase activity affect translation?
It enables wobble base pairing, allowing one tRNA to recognize multiple codons.
Can CRISPR be used to study tRNA-specific adenosine deaminase activity?
Yes, knockout, point mutation, knock-in, and overexpression models are available.
What is the evolutionary link between tRNA deaminases and ADARs?
They share a common ancestor, as shown by sequence and functional similarities.
What are the potential therapeutic targets for cancer involving this activity?
ADAT2 is a promising target for overcoming chemoresistance in colorectal cancer.
Conclusion
tRNA-specific adenosine deaminase activity (GO:0008251) is a fundamental RNA modification process with critical roles in translation and disease. Its conservation and links to cancer and genetic disorders make it a compelling research focus. Leveraging CRISPR models and advanced sequencing will further illuminate its mechanisms and therapeutic potential.
References
- 1. Soma A et al.. 2023. yaaJ, the tRNA-Specific Adenosine Deaminase, Is Dispensable in Bacillus subtilis.. Genes (Basel) 14(8) PMID: 37628567
- 2. Ramos J et al.. 2021. Detection of tRNA-specific adenosine deaminase activity and wobble inosine modification in human cell lysates.. Methods Enzymol 658:311-334 PMID: 34517952
- 3. Liu H et al.. 2020. Structure of a tRNA-specific deaminase with compromised deamination activity.. Biochem J 477(8):1483-1497 PMID: 32270856
- 4. Cheng CH et al.. 2026. ADAT2-mediated A-to-I tRNA modification promotes oncogenic translation and colorectal cancer progression and chemoresistance.. Mol Cancer 25(1) PMID: 41845367
- 5. Gerber A et al.. 1998. Tad1p, a yeast tRNA-specific adenosine deaminase, is related to the mammalian pre-mRNA editing enzymes ADAR1 and ADAR2.. EMBO J 17(16):4780-9 PMID: 9707437
- 6. Keegan LP et al.. 2000. The properties of a tRNA-specific adenosine deaminase from Drosophila melanogaster support an evolutionary link between pre-mRNA editing and tRNA modification.. Mol Cell Biol 20(3):825-33 PMID: 10629039
- 7. Maas S et al.. 2000. Sequence, genomic organization and functional expression of the murine tRNA-specific adenosine deaminase ADAT1.. Gene 243(1-2):59-66 PMID: 10675613
- 8. Hou Y et al.. 2007. Five novel mutations of RNA-specific adenosine deaminase gene with dyschromatosis symmetrica hereditaria.. Acta Derm Venereol 87(1):18-21 PMID: 17225010
